Figure 2

Gene expression profiling in endometrial CTC. (A) Significant expression levels of genes involved in signaling pathways reported altered in EC, (B) hormone pathways and (C) stem cell features, in CTC from high-risk EC patients compared to the background of unspecific immunoisolation. White boxes represent the gene expression levels in the group of healthy controls, light grey boxes those corresponding to FIGO Stages I and II EC patients while dark grey boxes those corresponding to FIGO Stages III-IV EC patients and recurrences. (Kruskal-Wallis test, *p < 0.05; **p < 0.01; ***p < 0.001).